Leukemia News and Features
A short course of cyclophosphamide can not only prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate need for the typical 6-month round of immune suppression medicines.
For pediatric patients with acute lymphoblastic leukemia (ALL), obesity increases risk of persistent disease
Obese pediatric patients with acute lymphoblastic leukemia (ALL) are more likely to have minimal residual disease.
For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.
Results of a phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy in a heavily pretreated cohort of patients.
Tyrosine kinase inhibitors (TKIs) may be effective for the treatment of acute lymphoblastic leukemia (ALL).
Leukemia Clinical Trials
Sign Up for Free e-newsletters
- Risk prediction improved by new classification in chronic lymphocytic leukemia
- Treatment options for HER2-positive breast cancer
- Antimicrobial agent triclosan, used in soaps and detergents, may cause cancer
- The Society for Integrative Oncology (SIO) and co-researchers issue a report card on complementary therapies for breast cancer
- Disparities in non-small cell lung cancer (NSCLC) treatment based on race, treatment center
- A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
- Early palliative care can cut hospital readmissions for cancer patients
- ONA Interview: Breaking the barriers to effective palliative care
- Fluorescent tattoos may improve self-esteem in patients receiving radiotherapy for breast cancer
- Cancer prehabilitation: One step toward improved outcomes
- Radiation exposure linked to aggressive thyroid cancers
- More patients opt for mastectomy despite limited, early-stage breast cancer
- Calcium channel blockers not found to increase risk of breast cancer
- Being overweight or obese may hide true nutritional status of patients with cancer
- Monitoring psychosocial function in radiotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|